Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ismael, Francisco Aomar Millán"'
Autor:
Ismael Francisco Aomar-Millán, Javier Martínez de Victoria-Carazo, Daniel Fernández Reyes, Úrsula Torres-Parejo, Laura Pérez Fernández, Silvia Martínez-Diz, Angel Ceballos Torres, Jairo López Gómez, Francesco Bizzarri, Enrique Raya Álvarez, Juan Salvatierra
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0283529 (2023)
ObjectiveTo assess the clinical outcome (death and/or Intensive Care Unit (ICU) admission) based on the time from hospital admission to the administration of anakinra and the possible usefulness of a "simplified" SCOPE score to stratify the risk of w
Externí odkaz:
https://doaj.org/article/0f75233889094485bfc5e5226cff4fd2
Autor:
Ismael Francisco Aomar-Millán, Juan Salvatierra, José Luis Callejas-Rubio, Enrique Raya-Álvarez
Publikováno v:
Reumatología Clínica. 19:120-121
Autor:
Ismael Francisco, Aomar-Millán, Juan, Salvatierra, José Luis, Callejas-Rubio, Enrique, Raya-Álvarez
Publikováno v:
Reumatología Clínica (English Edition). 19:120-121
Autor:
María Nuñez-Nuñez, Ismael Francisco Aomar-Millán, Juan Salvatierra, Úrsula Torres-Parejo, Francisco Anguita-Santos, José Hernández-Quero
Publikováno v:
Medicina Clinica (English Ed.)
Aim To assess clinical outcomes according to the immunosuppressive treatment administered to patients with severe SARS-CoV-2 pneumonia and moderate inflammation. Methods A retrospective observational cohort study involving 142 patients with severe CO
Autor:
Ismael Francisco, Aomar-Millán, Salvatierra, Juan, José, Luis Callejas-Rubio, Enrique, Raya-Álvarez
Publikováno v:
Reumatologia clinica.
Autor:
Ismael Francisco Aomar-Millán, Juan Salvatierra, Úrsula Torres-Parejo, Naya Faro-Miguez, José Luis Callejas-Rubio, Ángel Ceballos-Torres, María Teresa Cruces-Moreno, Francisco Javier Gómez-Jiménez, José Hernández-Quero, Francisco Anguita-Santos
Publikováno v:
Internal and Emergency Medicine
Introduction Little evidence appears to exist for the use of anakinra, a recombinant interleukin-1 receptor antagonist, after non-response to treatment with corticosteroids alone or combined with tocilizumab in patients with severe COVID-19 pneumonia
Publikováno v:
Internal and Emergency Medicine
Little evidence appears to exist for the use of anakinra, a recombinant interleukin-1 receptor antagonist, after non-response to treatment with corticosteroids alone or combined with tocilizumab in patients with severe COVID-19 pneumonia and moderate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d43859d3194766ea496a6e428433d12a
https://hdl.handle.net/10668/17335
https://hdl.handle.net/10668/17335
Autor:
Juan Salvatierra, José Hernández-Quero, María Nuñez-Nuñez, Ismael Francisco Aomar-Millán, Úrsula Torres-Parejo, Francisco Anguita-Santos
Publikováno v:
Medicina Clinica
Medicina Clínica
Medicina Clínica
Resumen Objetivos Analizar si existen diferencias en desenlaces clinicos segun el tratamiento inmunosupresor recibido en pacientes con neumonia grave por SARS-CoV-2 e inflamacion moderada. Metodos Estudio de cohortes retrospectivo de 142 pacientes co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84eb479d31f70d4bde6e4d28b815796c
https://hdl.handle.net/10668/17226
https://hdl.handle.net/10668/17226
Autor:
Francisco Javier Gómez-Jimenez, Ismael Francisco Aomar-Millán, Juan Salvatierra, Francisco Anguita-Santos, Naya Faro-Miguez, María Teresa Cruces-Moreno, Angel Ceballos-Torres, José Hernández Quero, José Luis Callejas-Rubio, Úrsula Torres-Parejo, David Vinuesa-García
Introduction: Little evidence appears to exists for the use of anakinra, a recombinant interleukin-1 receptor antagonist, after non-response to treatment with corticosteroids alone or combined with tocilizumab in patients with severe COVID-19 pneumon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fc2a0ad1087438d8bc81021339b138d
https://doi.org/10.21203/rs.3.rs-88775/v1
https://doi.org/10.21203/rs.3.rs-88775/v1
Autor:
José Luis Callejas Rubio, Manuela Moreno Higueras, Ismael Francisco Aomar Millán, Leopoldo Muñoz Medina, María López López, Ángel Ceballos Torres
Publikováno v:
Revista Espanola De Geriatria Y Gerontologia
Revista Española de Geriatría y Gerontología
Revista Española de Geriatría y Gerontología
RESUMEN INTRODUCCIÓN: el síndrome de tormenta de citoquinas (STC) es una complicación muy grave de los pacientes con infección por SARS-CoV-2. El tratamiento y la evolución en octogenarios no están bien definidos. Nuestro objetivo es describir